Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transplantation for Hematologic Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00143884
What this trial is testing

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Who this might be right for
LeukemiaLymphoma, Low-GradeLymphoma, Non-Hodgkin's+2 more
University of Michigan Rogel Cancer Center 30
Early research (Phase 1)Ended earlyNCT01818479
What this trial is testing

Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies

Who this might be right for
High Risk Hematologic Malignancies
University of Utah 10
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Not applicableNot Yet RecruitingNCT07572695
What this trial is testing

Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid LeukemiaAML, Relapsed/Refractory
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Large-scale testing (Phase 3)Study completedNCT00138112
What this trial is testing

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

Who this might be right for
Streptococcal SepsisHematologic Malignancies
Memorial Sloan Kettering Cancer Center 126
Post-approval studies (Phase 4)UnknownNCT05545202
What this trial is testing

A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation

Who this might be right for
Malignant LymphomaMultiple Myeloma
Pharmacosmos A/S 150
Testing effectiveness (Phase 2)Study completedNCT02168101
What this trial is testing

Determining the Feasibility of MLN9708 as Maintenance After Allogeneic Stem Cell Transplant for Multiple Myeloma

Who this might be right for
Multiple Myeloma
SCRI Development Innovations, LLC 9
Large-scale testing (Phase 3)Study completedNCT02288741
What this trial is testing

Tandem Melphalan and Autolog. SCT in MM Patients 60 to 70 Years of Age With and Without Induction Chemotherapy

Who this might be right for
Multiple Myeloma
WiSP Wissenschaftlicher Service Pharma GmbH 549
Testing effectiveness (Phase 2)Study completedNCT01349101
What this trial is testing

A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

Who this might be right for
Hematological Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78
Testing effectiveness (Phase 2)Active Not RecruitingNCT04904588
What this trial is testing

HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaMixed Phenotype Acute Leukemia+5 more
Center for International Blood and Marrow Transplant Research 300
Post-approval studies (Phase 4)UnknownNCT02938741
What this trial is testing

ATG Based Conditioning Regimen in HLA Related HSCT for Aggressive T-cell Tumors

Who this might be right for
Lymphoblastic Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 130
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Large-scale testing (Phase 3)Study completedNCT00799461
What this trial is testing

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Testing effectiveness (Phase 2)Ended earlyNCT00396383
What this trial is testing

Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation

Who this might be right for
Multiple Myeloma
Genzyme, a Sanofi Company 9
Testing effectiveness (Phase 2)Looking for participantsNCT04990102
What this trial is testing

Phase IB/II of CPX-351 for Relapse Prevention in AML

Who this might be right for
Acute Myeloid Leukemia (AML) in Remission
Georgetown University 24
Not applicableStudy completedNCT03198754
What this trial is testing

Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue

Who this might be right for
Cancer-related Problem/ConditionDepressionCircadian Rhythm Disorders
Icahn School of Medicine at Mount Sinai 73
Large-scale testing (Phase 3)Looking for participantsNCT05552222
What this trial is testing

Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 1,590
Testing effectiveness (Phase 2)Study completedNCT00561743
What this trial is testing

A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients

Who this might be right for
Multiple Myeloma
Janssen-Ortho Inc., Canada 50
Not applicableStudy completedNCT05961215
What this trial is testing

Scalp Cooling to Prevent Hair Loss in Patients Undergoing Stem Cell Transplantation for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cedars-Sinai Medical Center 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT02600208
What this trial is testing

Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device

Who this might be right for
Hematologic Malignancies
Julie-An M. Talano 60
Next Page